2025 Sol Sherry Distinguished Lecture in Thrombosisr – Saskia Middeldorp, MD, PhD


Saskia Middeldorp, MD, PhD
Saskia Middeldorp, MD, PhD

Saskia Middeldorp, MD, PhD

Radboud University Medical Center
Nijmegen, The Netherlands

 

Saskia Middeldorp is Professor of Medicine and Head of the Department of Internal Medicine of the Radboud University Medical Center in Nijmegen, the Netherlands. Before her transfer to Nijmegen in January 2021, she had been Full Professor of Medicine at Amsterdam University Medical Centers for more than 10 years, leading the clinical thrombosis and hemostasis research lines of the Department of Vascular Medicine. Since January 2023, Saskia Middeldorp is one of the four Research Domain Leaders in the Radboudumc Research Institution for Medical Innovation.

Her research focuses on several aspects of hereditary and acquired thrombophilia, women’s issues in thrombosis and hemostasis, and the clinical evaluation of new anticoagulants and antidotes. She is principal investigator of practice-changing trials such as the investigator-initiated ALIFE, ALIFE2 and Highlow randomized controlled trials.

Dr. Middeldorp is elected council member of the International Society of Thrombosis and Haemostasis, president-elect of the Netherlands Society of Internal Medicine, past chair of the INVENT-VTE network, and was associate editor of the Journal of Thrombosis and Haemostasis and editorial board member of Blood.

In December 2016, she held the Ham-Wasserman Lecture and received the accompanying award for pioneering work in inherited thrombophilia at the American Society of Hematology (ASH) meeting in San Diego. In October 2021, she received the Heijmans van den Bergh penning, a once-per-five-year honorary distinction of the Netherlands Internal Medicine Society for her achievements in science, education, governance and being a role model for young internists.

She was chair of the Thrombophilia Chapter of ASH VTE Guidelines (2023). Dr. Middeldorp co-authored the pregnancy chapter of the ASH pregnancy guideline in 2018, as well as the 9th Edition Antithrombotic Guidelines of the American College of Chest Physicians (ACCP) in 2012.

Dr. Middeldorp has supervised numerous PhD students and has co-authored more than 425 peer-reviewed papers and several book chapters, and reviews manuscripts for international scientific journals.

 

Four Days. Global Experts. Limitless Discovery.

Scientific Sessions 2025
November 7–10, 2025
New Orleans, Louisiana

#AHA25 is the global stage for breakthrough cardiovascular science, uniting experts, innovators, and future leader for four immersive days of discovery and collaboration.